Jun. 18 at 1:30 PM
$BRTX Another executive level hire to manage "this"? For the three months ended March 31, 2026, we generated total revenues of
$23,170, comprised of
$11,870 of product revenue and
$11,300 of royalty revenue, as compared to total revenues of
$25,000, comprised entirely of royalty revenue, for the three months ended March 31, 2025. Product revenue, which is derived from sales of our biocosmeceutical product offerings, increased by
$11,870 to
$11,870 from
$0, due to the commencement of commercial sales of our BioX product line during the three months ended March 31, 2026.
That is 11 thousand, eight hundred and seventy over 3 months. Not millions. Not billions.
